Ashish Acharya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ashish Acharya has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abhishek Premkumar
Internal Medicine Department, Freeman Health System, Joplin, MO 64804, USA
1 shared publication - Adnan Khan
Pulmonology and Critical Care Medicine Department, Freeman Health System, Joplin, MO 64804, USA
1 shared publication - Akram M. Eraky
Emergency Medicine, Freeman Health System, Joplin, MO 64804, USA
1 shared publication - Guy Grabau
Pulmonology and Critical Care Medicine Department, Freeman Health System, Joplin, MO 64804, USA
1 shared publication - Mark Jarosz
Internal Medicine Department, Freeman Health System, Joplin, MO 64804, USA
1 shared publication - Nichole Gadd
Emergency Medicine Department, Freeman Health System, Joplin, MO 64804, USA
1 shared publication
Latest Publications
- Open Access
- 25 April 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (2) , 213
Calcium Channel Blockers in Critical Care Medicine: Current Clinical Applications and Future Investigational Perspectives
Calcium channel blockers (CCBs) are frequently used in the emergency department and intensive care unit for a wide range of critical conditions, including atrial fibrillation, hypertensive emergencies, acute pulmonary edema with sympathetic crashing, pulmonary hypertension, and vasospastic syndromes. However, their toxicity can lead to significant hemodynamic compromise, underscoring the importance of understanding their pharmacologic effects and safety profile. This review summarizes the current applications of CCBs in critically ill patients, evaluates their safety in congestive heart failure, and highlights emerging therapeutic roles and recent advances in the management of CCB toxicity.
- 25 April 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (2) , 213
Open AccessCalcium Channel Blockers in Critical Care Medicine: Current Clinical Applications and Future Investigational Perspectives
Calcium channel blockers (CCBs) are frequently used in the emergency department and intensive care unit for a wide range of critical conditions, including atrial fibrillation, hypertensive emergencies, acute pulmonary edema with sympathetic crashing, pulmonary hypertension, and vasospastic syndromes. However, their toxicity can lead to significant hemodynamic compromise, underscoring the importance of understanding their pharmacologic effects and safety profile. This review summarizes the current applications of CCBs in critically ill patients, evaluates their safety in congestive heart failure, and highlights emerging therapeutic roles and recent advances in the management of CCB toxicity.